Verastem Stock Investor Sentiment
| VSTM Stock | USD 3.57 0.61 20.61% |
About 54% of Verastem's investors are presently thinking to get in. The analysis of the overall investor sentiment regarding Verastem suggests that some traders are interested. Verastem's investing sentiment overview a quick insight into current market opportunities from investing in Verastem. Many technical investors use Verastem stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Verastem |
Verastem Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Verastem can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Far too much social signal, news, headlines, and media speculation about Verastem that are available to investors today. That information is available publicly through Verastem media outlets and privately through word of mouth or via Verastem internal channels. However, regardless of the origin, that massive amount of Verastem data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Verastem news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Verastem relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Verastem's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Verastem alpha.
Verastem Performance against Dow Jones
Price Growth (%) |
| Timeline |
1 | Disposition of 3245 shares by Paterson Dan of Verastem at 2.16 subject to Rule 16b-3 | 08/05/2024 |
2 | Disposition of 2083 shares by Johnson John of Verastem at 49.92 subject to Rule 16b-3 | 08/20/2024 |
3 | Disposition of 244 shares by Paterson Dan of Verastem at 3.49 subject to Rule 16b-3 | 08/27/2024 |
4 | Acquisition by Robertson Michelle of 8333 shares of Verastem subject to Rule 16b-3 | 09/04/2024 |
5 | Verastem Oncology to Present at the 2024 Cantor Global Healthcare Conference | 09/10/2024 |
6 | Verastem vs. Kaya Head-To-Head Comparison | 09/16/2024 |
7 | Verastem CEO sells shares worth 688 to cover taxes | 09/18/2024 |
8 | Disposition of 336 shares by Stuglik Brian M of Verastem at 2.79 subject to Rule 16b-3 | 09/19/2024 |
9 | Verastem director Brian Stuglik sells shares worth 937 | 09/20/2024 |
10 | Disposition of tradable shares by Daniel Calkins of Verastem at 2.68 subject to Rule 16b-3 | 09/24/2024 |
11 | Verastems SWOT analysis oncology firms stock faces pivotal phase - Investing.com | 09/30/2024 |
12 | Verastem Oncology Announces Inducement Grants Under Nasdaq Listing Rule 5635 | 10/07/2024 |
13 | Verastem CFO sells shares worth 17 to cover tax obligations | 10/09/2024 |
14 | Verastem Oncology Presents Positive Updated RAMP 201 Data for Avutometinib and Defactinib Combination in Recurrent Low-Grade Serous Ovarian Cancer at the Intern... | 10/17/2024 |
15 | Verastems Buy Rating Reiterated at HC Wainwright | 10/18/2024 |
Check out Verastem Hype Analysis, Verastem Correlation and Verastem Performance. To learn how to invest in Verastem Stock, please use our How to Invest in Verastem guide.You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Verastem. If investors know Verastem will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Verastem listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.21) | Revenue Per Share 0.372 | Quarterly Revenue Growth (1.00) | Return On Assets (0.42) | Return On Equity (1.10) |
The market value of Verastem is measured differently than its book value, which is the value of Verastem that is recorded on the company's balance sheet. Investors also form their own opinion of Verastem's value that differs from its market value or its book value, called intrinsic value, which is Verastem's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Verastem's market value can be influenced by many factors that don't directly affect Verastem's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Verastem's value and its price as these two are different measures arrived at by different means. Investors typically determine if Verastem is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Verastem's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.